Literature DB >> 9330662

Serotyping and virulence factors of Pseudomonas aeruginosa clinical isolates.

A Hostacká1, V Majtán.   

Abstract

Pseudomonas aeruginosa is one of the major opportunistic human pathogens very often responsible for severe infections mainly in immunocompromised hosts. These bacteria may cause the broad spectrum of infections which are associated with urinary, respiratory and gastrointestinal tract, burn wounds, eyes as well as other sites. P. aeruginosa also significantly contributes to high morbidity and mortality rates of nosocomial infections. This microorganism produces a number of exoproducts which have been implicated in the pathogenesis of pseudomonas infections. Among them, the activity of elastase, proteinase and alginate were well established. The aim of the present study was to determine the distribution of P. aeruginosa strains (isolated from urinary and respiratory tract infections) in O-serotypes and to evaluate some of their characteristics (elastase, proteinase and alginate).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9330662

Source DB:  PubMed          Journal:  Acta Microbiol Immunol Hung        ISSN: 1217-8950            Impact factor:   2.048


  3 in total

1.  Assessment of panobacumab as adjunctive immunotherapy for the treatment of nosocomial Pseudomonas aeruginosa pneumonia.

Authors:  Y-A Que; H Lazar; M Wolff; B François; P-F Laterre; E Mercier; J Garbino; J-L Pagani; J-P Revelly; E Mus; A Perez; M Tamm; J-J Rouby; Q Lu; J Chastre; P Eggimann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-24       Impact factor: 3.267

2.  Toxinogenicity and markers of pathogenicity of Pseudomonas aeruginosa strains isolated from patients with tumor diseases.

Authors:  V Majtán; A Hostacká; L Majtánová; J Trupl
Journal:  Folia Microbiol (Praha)       Date:  2002       Impact factor: 2.099

3.  Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes.

Authors:  Qin Lu; Philippe Eggimann; Charles-Edouard Luyt; Michel Wolff; Michael Tamm; Bruno François; Emmanuelle Mercier; Jorge Garbino; Pierre-François Laterre; Holger Koch; Verena Gafner; Michael P Rudolf; Erkan Mus; Antonio Perez; Hedvika Lazar; Jean Chastre; Jean-Jacques Rouby
Journal:  Crit Care       Date:  2014-01-15       Impact factor: 9.097

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.